When most of us think about living to a ripe old age, we envision celebrating our 90th birthday, still in good health. Maybe a few of us will even make it to centenarian status
For me, such a best-case scenario sounds preposterously pessimistic. With advances in AI-enabled diagnostics, wearables, regenerative medicine, age-reversing pills, and other longevity-focused areas of innovation, a child born today can expect to live well over 100. In the much longer term, it’s within the realm of possibility that we could be looking at living to 200 years or more
As founder of the Longevity Vision Fund, a venture vehicle dedicated to breakthroughs in age-related disease, I have made investments to date in 16 companies in areas from AI-enabled drug discovery to cancer-detecting blood tests to organ regeneration. The common thread is that each is working on advances that, if successful, could help more of us stick around in corporeal form a little longer
